Skip to main content

Find Clinical Trials

Home
Conditions
Restless Legs Syndrome

Clinical trial condition

Restless Legs Syndrome

Explore clinical trials studying Restless Legs Syndrome. Study availability and eligibility vary by location and protocol.

199 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Restless Legs Syndrome trial results

Completed

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

NCT00375284

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: 248.616.065 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

248.616.028 Boehringer Ingelheim Investigational Site Dothan, Alabama, United States

248.616.035 Boehringer Ingelheim Investigational Site Mesa, Arizona, United States

248.616.025 Boehringer Ingelheim Investigational Site Peoria, Arizona, United States

View all 52 locations

View Trial Details

Completed

Restless Legs Syndrome in Stroke Patients

NCT01967303

Conditions: Brain Diseases, Brain Ischemia, Cardiovascular Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Validation Study for an Unobtrusive Online Sleep Measurement System

NCT01633151

Conditions: Apnea, Dyssomnias, Mental Disorders, +13 more
Locations: Helsinki Sleep Clinic, Vitalmed Research Centre Helsinki, Finland

View Trial Details

Completed

Comprehensive Police Fatigue Management Program

NCT00246051

Conditions: Apnea, Chronobiology Disorders, Dyssomnias, +18 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Simulated Driving Study in Restless Legs Syndrome

NCT01332318

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: GSK Investigational Site Albuquerque, New Mexico, United States

View Trial Details

Completed

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

NCT01455012

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Berlin, Germany

Kassel, Germany

Marburg, Germany

München, Germany

View Trial Details

Completed

Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.

NCT00311363

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

XP13512 vs. Placebo in Patients With Restless Legs Syndrome.

NCT00365352

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome

NCT01332305

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: GSK Investigational Site Dallas, Texas, United States

View Trial Details

Completed

XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.

NCT00333359

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Not specified

View Trial Details